Twitter icon Email alerts icon Latest News RSS icon Magazine icon Stay connected:

Citywire printed articles sponsored by:


View the article online at http://citywire.co.uk/wealth-manager/article/a639698

Garrett-Cox takes aim at Alliance Trust critics

by Rachael Revesz on Dec 04, 2012 at 13:14

Di Bon has also added Roche, the Swiss pharmaceuticals company, as a pioneer in personalised medicine, as well as Qualcomm, a US mobile technology company, which is now the second largest holding in the trust.

‘Once we identify our best ideas we make sure that, over time, they can have a very meaningful impact instead of being diluted across a number of lower conviction holdings,’ he said.

Sign in / register to view full article on one page

leave a comment

Please sign in here or register here to comment. It is free to register and only takes a minute or two.

News sponsored by:

Citywire 10k run: the 28 teams & 173 runners set to do battle

We reveal the teams and runners who have committed to take part in our annual fundraiser at Regent's Park later this month.

Today's top headlines

More about this:

Look up the shares

  • Alliance Trust PLC
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Look up the fund managers

  • Katherine Garrett-Cox
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them

More from us

Archive

Aberdeen Live supplement: Fundamentals point to ongoing flows and solid returns from EMD

After a record year for inflows and market-leading performance in 2012, emerging market debt has taken a large step towards the mainstream. Our recent debate covers the outlook for the asset class this year and where opportunities can be found.

On the road

Click here to find out more from the Audience Development team.

Sorry, this link is not
quite ready yet